Miyaguchi M, Olofsson J, Hellquist H B
Department of Otolaryngology, Kagawa Medical School, Japan.
Clin Otolaryngol Allied Sci. 1991 Oct;16(5):466-9. doi: 10.1111/j.1365-2273.1991.tb01041.x.
The expression of EGFR was determined immunohistochemically in two groups of patients with glottic carcinoma, one that recurred after a full course of radiotherapy and one that did not. Using a 4-graded scale (-,+,++, ) 80% (12/15) of the recurrent carcinomas had a staining intensity and proportion of stained cells of ++ or more. The same figure for non-recurrent carcinomas was 39% (7/18). The difference is statistically significant (chi-squared with Yates' correction, P less than 0.05). The results indicate that an increased expression of EGFR may influence the rate of recurrence of glottic squamous cell carcinoma after radiotherapy.